Oncologists Have Low Awareness of LGBTQ Issues

Share this content:
Oncologists Have Low Awareness of LGBTQ Issues
Oncologists Have Low Awareness of LGBTQ Issues

FRIDAY, Jan. 25, 2019 (HealthDay News) -- Most oncologists report a lack of knowledge about treating lesbian, gay, bisexual, transgender, and queer/questioning (LGBTQ) patients, according to survey results published online Jan. 16 in the Journal of Clinical Oncology.

Matthew B. Schabath, Ph.D., from the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, and colleagues used the American Medical Association Physician Masterfile to identify 450 oncologists from 45 National Cancer Institute-Designated Comprehensive Cancer Centers for a survey. The authors evaluated oncologists' attitudes and knowledge about LGBTQ health and institutional practices. Responses from 149 oncologists were included.

The researchers found high agreement (65.8 percent) regarding the importance of knowing the gender identity of patients, but there was low agreement (39.6 percent) regarding the importance of knowing sexual orientation. Seven in 10 respondents had interest in receiving education regarding the unique health needs of LGBTQ patients. Knowledge questions revealed high percentages of "neutral" and "do not know or prefer not to answer" responses. After completing the survey, respondents' confidence regarding knowledge of health needs for LGB and transgender patients significantly declined compared with their confidence before completing the survey (53.1 to 38.9 percent and 36.9 to 19.5 percent, respectively).

"At the institutional level, education and further training should be offered to physicians so they can be both culturally sensitive and clinically informed about LGBTQ cancer issues," a coauthor said in a statement.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA: Gout Drug Uloric Increases Risk of Death

FDA: Gout Drug Uloric Increases Risk of Death

Medication is associated with increased risk of heart-related death and death from all causes

Since Early 2000s, Overdose Death Rates Are Highest in U.S.

Since Early 2000s, Overdose Death Rates Are Highest ...

U.S. was not an outlier in terms of drug overdose mortality prior to the early 2000s

National Health Spending Set to Increase 5.5 Percent Annually

National Health Spending Set to Increase 5.5 Percent ...

Long-observed demographic and economic factors expected to drive growth in health spending

is free, fast, and customized just for you!




Already a member?

Sign In Now »